RNA, U2 small nuclear 7, pseudogene (RNU2-7P)

RNA, U2 small nuclear 7, pseudogene (RNU2-7P) is annotated as a pseudogene of the U2 small nuclear RNA gene family[1][4]. U2 small nuclear RNAs are essential components of the spliceosome, involved in splicing of pre-mRNA[3]. However, RNU2-7P itself is classified as a pseudogene, indicating it does not encode a functional product and is not known to be transcribed or to participate directly in splicing or other biological processes[1][4]. It is not a protein, receptor, enzyme, or transporter, and there is no evidence that RNU2-7P serves as a therapeutic or biological target, nor is it associated with any known disease role, pharmacologic interaction, or therapeutic modality[1][4]. The functional U2 snRNA genes themselves (such as RNU2-1 or RNU2-2) have established roles and, when mutated, can cause disease, but this does not apply to RNU2-7P pseudogene copies[2][3]. Key points: - The entry is not a protein, receptor, enzyme, or therapeutic target. - It is a pseudogene, not generally expressed or functional. - No disease roles, drug interactions, or clinical significance are established for RNU2-7P. - If searching for a spliceosome component, refer instead to functional U2 snRNA genes (e.g., RNU2-1, RNU2-2), not their pseudogenes[2]. There is something wrong with this target as a therapeutic target—it is not a functional molecule nor considered for pharmacologic targeting.

Other names

RNU2-7PU2 snRNA pseudogene 7